PathToScale: The PERSIST Trial
Abroad (travel likely)Recruiting
Conditions
Oral Pre-exposure Prophylaxis (PrEP) · Long-acting Injectable Cabotegravir for PrEP
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Community Health Science Unit, Lilongwe, Malawi
Contact: Study coordinator (Washington Ozituosauka)
Study leads
Charles Holmes, MD, MPH
Principal Investigator
Georgetown University